BREAKING
Home » Archive by Category "Vaccines" (Page 3)

Rabies: Thomas Jefferson University researchers develop better vaccine

By

Every year, more than 59,000 people around the world die of rabies and there remains no cheap and easy vaccine regimen to prevent the disease in humans. Now, researchers report in PLOS Neglected Tropical...

Ebola vaccine, Ervebo, receives final approval in Europe

By

The European Medicines Agency has recommended granting a conditional marketing authorisation in the European Union for Ervebo (rVSVΔG-ZEBOV-GP), the first vaccine for active immunisation of individuals...

Investigational VesiculoVax vaccine protects macaques against several hemorrhagic fever viruses endemic in Africa

By

Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping...

Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure

By

Takeda Pharmaceutical Company Limited announced that results from the primary endpoint analysis of the ongoing pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial of...

Fluzone® High-Dose Quadrivalent vaccine receives FDA approval for use in adults 65 years of age and older

By

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and older. Fluzone® High-Dose...

Lassa Fever Vaccine: Phase 1 clinical trial begins

By

Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness Innovations – announced today the first administration to healthy volunteers in a Phase 1 clinical trial with Themis’ vaccine...

Intranasal anthrax vaccine: BlueWillow Receives FDA Clearance to Begin Phase 1 Study

By

BlueWillow Biologics®, a clinical-stage biopharmaceutical company, announced this week that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for BW-1010,...

Rabies update: Rabies in the Americas (RITA) to host webinar on current guidelines and recommendations

By

Rabies in the Americas (RITA) has announced an upcoming webinar scheduled for November 1, from 9 am-1230 pm CDT, which will go over recent World Health Organization (WHO) recommendations on human rabies...

New effective vaccines for Lyme disease are coming

By

There is no effective vaccine currently available to prevent Lyme disease in humans. Experts from academia, government, and industry convened at Cold Spring Harbor Laboratory’s Banbury Center to...

vaccines

Global Vaccination Summit begins Monday to fight vaccine hesitancy

By

Individuals and parents have become increasingly wary about vaccines and confidence in them has dropped to an all-time low. During this crisis of trust, vaccination and infectious disease scientists and...